Physician profile
Joseph J Doerr
NPI 1427052703
$4,937.50
in general payments reported to CMS, 2019-2025
17 companies · $934 in 2025
The $934 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2020: $342 · 2021: $868 · 2022: $373 · 2023: $584 · 2024: $690 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,208.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $936.93 | 2021-2025 | Ubrelvy, Qulipta |
| Biodelivery Sciences International, INC. | $838.79 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $664.97 | 2019-2025 | Relistor |
| Teva Pharmaceuticals USA, INC. | $592.76 | 2020-2025 | Ajovy |
| Pfizer INC. | $430.06 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $395.87 | 2019-2021 | |
| Indivior INC. | $214.52 | 2019-2020 | |
| Valinor Pharma, LLC | $202.62 | 2023-2025 | Movantik |
| Daiichi Sankyo INC. | $153.60 | 2019 | |
| Lundbeck LLC | $125.00 | 2025 | Vyepti |
| Lilly USA, LLC | $107.44 | 2019-2024 | Emgality |
| Sanofi-Aventis U.S. LLC | $87.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $67.25 | 2019-2021 | |
| Fidia Pharma USA INC. | $35.51 | 2019 | |
| Idorsia Pharmaceuticals US INC | $31.06 | 2023 | Quviviq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.92 | 2023 | Belsomra |
| Zyla Life Sciences, INC. | $24.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Doerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.